Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Menthoxyl
- Development stage
- Unknown
- Lead developer
- Abacus Pharma
- Modality
- Small Molecules
- Administration
- Inhalation, Intranasal, Oral
01
Overview
Menthoxyl is an over-the-counter (OTC) herbal combination product distributed by Abacus Pharma in East Africa, including Uganda, Kenya, and Rwanda. It is available in formulations such as Menthoxyl Double Action Herbal Cough Lozenges and Menthoxyl Inhaler. The active ingredients of Menthoxyl are menthol and eucalyptus oil, which provide soothing, counter-irritant, and decongestant effects. It is primarily indicated for the temporary relief of cough, sore throat, hoarseness, and nasal congestion associated with colds and flu.
- Brand names
- MenthoxylMenthoxyl Double Action Herbal Cough LozengesMenthoxyl Inhaler
- Other names
- Menthoxyl Herbal Cough TabletsMenthoxyl Lozenges
02
Targets
TRPM8 (Transient receptor potential cation channel subfamily M member 8)
Beyond the preview
Go deeper on Menthoxyl.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Menthoxyl.